Envoy Medical
COCH

Envoy Medical (COCH) earnings history

Most recent quarter

Period end
Sep 30, 2025
EPS actual
−$0.35
EPS estimate
−$0.24
EPS surprise
−45.83%
Revenue
$42,000.00
Reported
Nov 10, 2025

Earnings history

PeriodReportedEPS estimateEPS actualSurpriseRevenueFiling
Q3 2025Nov 10, 2025−$0.24−$0.35−45.83%$42,000.00SEC
Q2 2025Jul 31, 2025−$0.30−$0.32−5.79%$78,000.00SEC
Q1 2025May 1, 2025−$0.36−$0.29+18.88%$46,000.00SEC
Q4 2024Mar 31, 2025−$0.31−$0.53−69.17%$42,000.00SEC
Q3 2024Nov 14, 2024−$0.27−$0.37−35.78%$56,000.00SEC
Q2 2024Aug 12, 2024−$0.25−$0.27−6.93%$68,000.00SEC
Q1 2024May 15, 2024−$0.23−$0.32−42.22%$59,000.00SEC
Q4 2023Apr 1, 2024−$0.19−$0.30−57.89%$95,000.00SEC
Q3 2023Nov 17, 2023$0.13$0.13+0.00%$80,000.00SEC

Quarterly revenue

Q3 2023
$80,000.00
Q4 2023
$95,000.00
Q1 2024
$59,000.00
Q2 2024
$68,000.00
Q3 2024
$56,000.00
Q4 2024
$42,000.00
Q1 2025
$46,000.00
Q2 2025
$78,000.00
Q3 2025
$42,000.00

Frequently asked questions

  • When did Envoy Medical (COCH) last report earnings?

    Envoy Medical last reported on Nov 10, 2025, covering fiscal Q3 2025.

  • Did COCH beat earnings estimates?

    No. Envoy Medical reported EPS of −$0.35 for Q3 2025 against a −$0.24 estimate — a 45.83% miss.

  • How much revenue did COCH report last quarter?

    Envoy Medical reported $42,000.00 in revenue for Q3 2025, against a consensus estimate of $60,000.00.

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.